Skip to content
The Nexus
HEALTHJun 23 · 12:41 UTCEURACTIVBrian Maguire

EU’s off-patent medicines industry calls for industrial strategy at Athens summit [Advocacy Lab]

The EU’s off-patent medicines industry is advocating for an industrial strategy during the Athens summit, where Greece's growing role as a pharmaceutical manufacturing hub is highlighted ahead of its 2027 EU Council Presidency.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Medicines for Europe conferenceorganizationGreeceplaceEU Council PresidencytopicAthens summitplace
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting